Janus Henderson Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,777
| Closed | -$149K | – | 2546 |
|
|
2024
Q1 | $149K | Buy |
19,777
+2
| +0% | +$15 | ﹤0.01% | 2470 |
|
|
2023
Q4 | $183K | Sell |
19,775
-37
| -0.2% | -$343 | ﹤0.01% | 2457 |
|
|
2023
Q3 | $201K | Buy |
19,812
+4
| +0% | +$40 | ﹤0.01% | 2385 |
|
|
2023
Q2 | $248K | Sell |
19,808
-25
| -0.1% | -$313 | ﹤0.01% | 2353 |
|
|
2023
Q1 | $231K | Buy |
+19,833
| New | +$231K | ﹤0.01% | 2422 |
|
|
2022
Q4 | – | Sell |
-2,218,438
| Closed | -$21.5M | – | 2475 |
|
|
2022
Q3 | $21.5M | Buy |
2,218,438
+992,197
| +81% | +$9.62M | 0.01% | 657 |
|
|
2022
Q2 | $17.8M | Sell |
1,226,241
-71,626
| -6% | -$1.04M | 0.01% | 586 |
|
|
2022
Q1 | $33.9M | Sell |
1,297,867
-80,512
| -6% | -$2.1M | 0.02% | 612 |
|
|
2021
Q4 | $54.6M | Sell |
1,378,379
-20,428
| -1% | -$809K | 0.02% | 515 |
|
|
2021
Q3 | $70M | Sell |
1,398,807
-5,562
| -0.4% | -$278K | 0.03% | 458 |
|
|
2021
Q2 | $78M | Sell |
1,404,369
-43,463
| -3% | -$2.41M | 0.03% | 442 |
|
|
2021
Q1 | $67.7M | Buy |
1,447,832
+10,138
| +0.7% | +$474K | 0.03% | 465 |
|
|
2020
Q4 | $62.6M | Buy |
1,437,694
+186,266
| +15% | +$8.11M | 0.03% | 485 |
|
|
2020
Q3 | $45.8M | Buy |
1,251,428
+15,442
| +1% | +$565K | 0.02% | 519 |
|
|
2020
Q2 | $36.1M | Buy |
1,235,986
+57,282
| +5% | +$1.67M | 0.02% | 569 |
|
|
2020
Q1 | $30.8M | Buy |
1,178,704
+1,035,031
| +720% | +$27.1M | 0.02% | 571 |
|
|
2019
Q4 | $4.99M | Buy |
143,673
+5,640
| +4% | +$196K | ﹤0.01% | 1056 |
|
|
2019
Q3 | $4.37M | Buy |
+138,033
| New | +$4.37M | ﹤0.01% | 1074 |
|